Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Mannanoligosaccharides

Prebiotic

Useful mainly for no established human use; mostly studied as an animal feed additive.

Quick decision guide

May help most

no established human use; mostly studied as an animal feed additive

Common dosing range

not established for humans

When to expect effects

Uncertain

Watch out for

human data are essentially absent; do not extrapolate livestock results to people

What is it

Mannanoligosaccharides (MOS) are short mannose-based carbohydrate chains, typically derived from the cell wall of yeast (Saccharomyces cerevisiae). They are used as a prebiotic-type feed additive, where they are thought to bind certain gut pathogens and support gut immunity. Almost all evidence comes from animal and aquaculture studies, with little human research.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

you accept that human evidence is essentially absent and are experimenting cautiously

Probably skip if

you want a benefit shown in human trials
you have a yeast allergy
you expect results comparable to studied prebiotics like inulin

Evidence at a glance

gut microbiota and pathogen binding

Mixed Evidence
Effect
Unknown in humans
Best fit
not established in humans
Time
Uncertain

Evidence for 1 use

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

gut microbiota and pathogen binding

Mechanism only
Mixed Evidence

MOS can bind mannose-specific fimbriae on certain enteric bacteria and may modulate gut microbiota and immune markers, effects demonstrated largely in poultry, swine, and aquaculture. Human studies are sparse and do not establish a clinical benefit. Any effect in people is inferred from animal mechanisms rather than shown directly.

Effect size
Unknown in humans
Time to effect
Uncertain
Best fit
not established in humans

Bottom line: MOS shows pathogen-binding and microbiota effects in animals, but there is essentially no human evidence of benefit.

Evidence is mixed

Evidence is dominated by animal and aquaculture studies; controlled human trials are lacking.

How to take it

1. Typical dose
no validated human dose
2. Timing
as directed by the product
3. With food
with food
4. How long to try
short trial only

What to track

digestive comfort
bloating or gas
bowel regularity

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

gasbloating (expected for fermentable carbohydrates)

Who should avoid it

  • people with yeast allergy or sensitivity

Pregnancy & breastfeeding

No human safety data in pregnancy; avoid supplemental use.

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

states the source (e.g., yeast cell wall)
discloses amount per serving
intended for human use rather than animal feed

Be skeptical of

boosts immunity
treats infections
human benefits extrapolated from livestock studies

References by claim

gut microbiota and pathogen binding

Wang et al., 2018PubMed (2018) link

Gouveia et al., 2013PMC (2013) link

Track Mannanoligosaccharides with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.